Podcast
MedEdTalks - Pediatrics
Hosted by Vindico Medical Education · ENGLISH
MedEdTalks Pediatrics is an accredited educational podcast for providers to learn more about treating patients with Pediatrics diseases/disorders. Discover all content and topics by visiting mededtalks.com.
8episodes
Episodes
Newest firstAll episodes
Overcoming HPV Vaccine Hesitancy With Drs. Charles P. Vega and Anne Teitelman
Jun 24, 202200:15:27Tap to summarizeIn this podcast, expert clinicians discuss strategies for overcoming HPV vaccine hesitancy.
Transcribe →HPV Vaccination Schedules in Pediatric Patients With Drs. Charles P. Vega and Stan L. Block
Jun 24, 202200:16:05Tap to summarizeIn this podcast, expert clinicians discuss HPV vaccination schedules for pediatric patients.
Transcribe →Understanding the Risk of HPV Infection With Drs. Charles P. Vega and Rachel N. Caskey
Jun 24, 202200:16:31Tap to summarizeIn this podcast, expert clinicians will discuss the risk of HPV infection.
Transcribe →Understanding the Burden of Pediatric HPV With Drs. Charles P. Vega and Stan L. Block
Jun 24, 202200:18:01Tap to summarizeIn this podcast, expert clinicians will discuss the burden of pediatric HPV infection.
Transcribe →
Dr. Charles Vega and Dr. Michael Simon Discuss a Case Involving a High-Risk Patient With Influenza
Aug 31, 202000:15:41Tap to summarizeWhile the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention (CDC) estimates that influenza has resulted in between 9.2 million and 35.6 million illnesses, between 140,000 and 710,000 hospitalizations, and between 12,000 and 56,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. Antivirals with different targets and different mechanisms of action provide multiple therapeutic options and hold promise in improving treatment effectiveness, especially in pediatric and adolescent patients. In this podcast series, expert clinicians will discuss the latest evidence regarding the use of antiviral agents for the treatment of patients with influenza who are at normal or high risk for complications and the use of antiviral agents for influenza treatment based on their efficacy and ability to reduce the transmission of the disease. For CME Credit, click here: https://tinyurl.com/pediatricss1e3
Transcribe →
Dr. Paul Auwaerter and Dr. Charles Vega Review the Therapies Used to Treat Influenza
Aug 31, 202000:15:08Tap to summarizeWhile the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention (CDC) estimates that influenza has resulted in between 9.2 million and 35.6 million illnesses, between 140,000 and 710,000 hospitalizations, and between 12,000 and 56,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. Antivirals with different targets and different mechanisms of action provide multiple therapeutic options and hold promise in improving treatment effectiveness, especially in pediatric and adolescent patients. In this podcast series, expert clinicians will discuss the latest evidence regarding the use of antiviral agents for the treatment of patients with influenza who are at normal or high risk for complications and the use of antiviral agents for influenza treatment based on their efficacy and ability to reduce the transmission of the disease. For CME Credit, click here: https://tinyurl.com/pediatricss1e2
Transcribe →
Dr. Paul Auwaerter and Dr. Charles Vega Discuss the Latest in Diagnosing and Managing Patients With Influenza
Aug 31, 202000:15:07Tap to summarizeWhile the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention (CDC) estimates that influenza has resulted in between 9.2 million and 35.6 million illnesses, between 140,000 and 710,000 hospitalizations, and between 12,000 and 56,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. Antivirals with different targets and different mechanisms of action provide multiple therapeutic options and hold promise in improving treatment effectiveness, especially in pediatric and adolescent patients. In this podcast series, expert clinicians will discuss the latest evidence regarding the use of antiviral agents for the treatment of patients with influenza who are at normal or high risk for complications and the use of antiviral agents for influenza treatment based on their efficacy and ability to reduce the transmission of the disease. For CME Credit, complete activity here: https://tinyurl.com/pediatricss1e1
Transcribe →Influenza Update! Advanced Practice Pearls on Treatment
Aug 4, 202000:00:35Tap to summarizeThis CME/CNE series is targeted to pediatric nurse practitioners and other health care professionals involved in the management of patients with influenza.
Transcribe →